That is a signal worth serious attention as TRIUMPH-1, TRIUMPH-2 and TRIUMPH-3 mature through 2026 and 2027
Thus, the conjugate seemingly harnesses the dual pharmacological benefits of hypothalamic GLP-1 receptor agonism and NMDA receptor antagonism while mitigating adverse behavioural effects linked to the latter
Meet our doctors Last reviewed: 03 Jul 2026 Sources Foundayo, LillyDirect [accessed 29 June 2026] Mounjaro KwikPen 10mg solution for injection in prefilled pen, emc [accessed 29 June 2026] Nevolat 6 mg/ml solution for injection in prefilled pen, emc [accessed 29 June 2026] Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity, The New England Journal of Medicine (NEJM) [accessed 29 June 2026] Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment, NEJM [accessed 29 June 2026]
Hydration: Sip on clear fluids like water, herbal teas, or diluted fruit juices to stay hydrated and reduce nausea
When to Go the Compounding Route Instead Many patients decide that pursuing insurance coverage isn't worth the time and frustration, particularly when affordable compounded alternatives are available
24+ Months: Long-Term Maintenance Decision At this point, patients and their physician make a shared decision: attempt a carefully managed tapering and transition to maintenance, or continue long-term medication for ongoing metabolic management
